By combining transcriptomic profiling of human and murine datasets with functional experiments in diabetic mice and high glucose-stimulated endothelial cells, we identified Efnb2 as a central regulator of microvascular dysfunction in DCM. This evidence concerns the gene EFNB2 and familial dilated cardiomyopathy.